This protocol is judged by an institutional evaluate board, an impartial team that critiques any medical trials involving human beings. If a study includes a Agenda I drug, when the board approves the protocol as ethical, the scientists should submit an application for an investigational new drug (IND) variety with the FDA.Customers documented litt